Top compounds associated with response to RAD9A


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC -0.084 0.02
mRNA Repligen 136 CTRPv2 pan-cancer AAC 0.094 0.02
mRNA paclitaxel UHNBreast pan-cancer AAC -0.67 0.02
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA Bryostatin 1 GDSC1000 pan-cancer AAC -0.088 0.02
mRNA TKI258 CCLE pan-cancer AAC -0.12 0.02
mRNA FH535 GDSC1000 pan-cancer AAC -0.086 0.02
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.09 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.02
mRNA NSC23766 CTRPv2 pan-cancer AAC 0.085 0.02
Download CSV